Thrombotic risk determined by rare and common SERPINA1 variants in a population-based cohort study
(2022) In Journal of Thrombosis and Haemostasis 20(6).- Abstract
 - Background: Severe alpha-1-antitrypsin deficiency (AATD), phenotype PiZZ, was associated with venous thromboembolism (VTE) in a case-control study. Objectives: This study aimed to determine the genetic variation in the SERPINA1 gene and a possible thrombotic risk of these variants in a population-based cohort study. Patients/Methods: The coding sequence of SERPINA1 was analyzed for the Z (rs28929474), S (rs17580), and other qualifying variants in 28,794 subjects without previous VTE (born 1923–1950, 60% women), who participated in the Malmö Diet and Cancer study (1991–1996). Individuals were followed from baseline until the first event of VTE, death, or 2018. Results: Resequencing the coding sequence of SERPINA1 identified 84 variants in... (More)
 - Background: Severe alpha-1-antitrypsin deficiency (AATD), phenotype PiZZ, was associated with venous thromboembolism (VTE) in a case-control study. Objectives: This study aimed to determine the genetic variation in the SERPINA1 gene and a possible thrombotic risk of these variants in a population-based cohort study. Patients/Methods: The coding sequence of SERPINA1 was analyzed for the Z (rs28929474), S (rs17580), and other qualifying variants in 28,794 subjects without previous VTE (born 1923–1950, 60% women), who participated in the Malmö Diet and Cancer study (1991–1996). Individuals were followed from baseline until the first event of VTE, death, or 2018. Results: Resequencing the coding sequence of SERPINA1 identified 84 variants in the total study population, 21 synonymous, 62 missense, and 1 loss-of-function variant. Kaplan-Meier analysis showed that homozygosity for the Z allele increased the risk of VTE whereas heterozygosity showed no effect. The S (rs17580) variant was not associated with VTE. Thirty-one rare variants were qualifying and included in collapsing analysis using the following selection criteria, loss of function, in frame deletion or non-benign (PolyPhen-2) missense variants with minor allele frequency (MAF) (Less)
 
    Please use this url to cite or link to this publication:
    https://lup.lub.lu.se/record/1ab099e7-90b8-4ca2-8d8e-874c69777266
- author
 - 						Manderstedt, E.
	; 						Halldén, Christer
	; 						Lind-Halldén, Christina
	; 						Elf, J.
				LU
	; 						Svensson, P.J.
				LU
	; 						Engström, G.
				LU
	; 						Melander, O.
				LU
				
	; 						Baras, Aris
	; 						Lotta, Luca A.
	 and 						Zöller, B.
				LU
				
	 - author collaboration
 - organization
 - 
                
- Clinical Coagulation, Malmö (research group)
 - EpiHealth: Epidemiology for Health
 - Cardiovascular Research - Epidemiology (research group)
 - Cardiovascular Research - Hypertension (research group)
 - EXODIAB: Excellence of Diabetes Research in Sweden
 - MultiPark: Multidisciplinary research focused on Parkinson's disease
 - Family medicine, cardiovascular medicine and genetics (research group)
 
 - publishing date
 - 2022
 - type
 - Contribution to journal
 - publication status
 - published
 - subject
 - keywords
 - alpha-1-antitrypsin, epidemiology, genetics, SERPINA1, venous thromboembolism
 - in
 - Journal of Thrombosis and Haemostasis
 - volume
 - 20
 - issue
 - 6
 - publisher
 - Elsevier
 - external identifiers
 - 
                
- scopus:85126760431
 - pmid:35263815
 
 - ISSN
 - 1538-7933
 - DOI
 - 10.1111/jth.15696
 - language
 - English
 - LU publication?
 - yes
 - id
 - 1ab099e7-90b8-4ca2-8d8e-874c69777266
 - date added to LUP
 - 2022-09-05 14:23:24
 - date last changed
 - 2025-10-14 12:26:14
 
@article{1ab099e7-90b8-4ca2-8d8e-874c69777266,
  abstract     = {{Background: Severe alpha-1-antitrypsin deficiency (AATD), phenotype PiZZ, was associated with venous thromboembolism (VTE) in a case-control study. Objectives: This study aimed to determine the genetic variation in the SERPINA1 gene and a possible thrombotic risk of these variants in a population-based cohort study. Patients/Methods: The coding sequence of SERPINA1 was analyzed for the Z (rs28929474), S (rs17580), and other qualifying variants in 28,794 subjects without previous VTE (born 1923–1950, 60% women), who participated in the Malmö Diet and Cancer study (1991–1996). Individuals were followed from baseline until the first event of VTE, death, or 2018. Results: Resequencing the coding sequence of SERPINA1 identified 84 variants in the total study population, 21 synonymous, 62 missense, and 1 loss-of-function variant. Kaplan-Meier analysis showed that homozygosity for the Z allele increased the risk of VTE whereas heterozygosity showed no effect. The S (rs17580) variant was not associated with VTE. Thirty-one rare variants were qualifying and included in collapsing analysis using the following selection criteria, loss of function, in frame deletion or non-benign (PolyPhen-2) missense variants with minor allele frequency (MAF)}},
  author       = {{Manderstedt, E. and Halldén, Christer and Lind-Halldén, Christina and Elf, J. and Svensson, P.J. and Engström, G. and Melander, O. and Baras, Aris and Lotta, Luca A. and Zöller, B.}},
  issn         = {{1538-7933}},
  keywords     = {{alpha-1-antitrypsin; epidemiology; genetics; SERPINA1; venous thromboembolism}},
  language     = {{eng}},
  number       = {{6}},
  publisher    = {{Elsevier}},
  series       = {{Journal of Thrombosis and Haemostasis}},
  title        = {{Thrombotic risk determined by rare and common SERPINA1 variants in a population-based cohort study}},
  url          = {{http://dx.doi.org/10.1111/jth.15696}},
  doi          = {{10.1111/jth.15696}},
  volume       = {{20}},
  year         = {{2022}},
}